2 documents found, page 1 of 1

Sort by Issue Date

Corrigendum to IP1867B suppresses the insulin-like growth factor 1 receptor (IG...

Mihajluk, K.; Simms, C.; Reay, M.; A Madureira, Patricia; Howarth, A.; Murray, P.; Nasser, S.; Duckworth, C. A.; Pritchard, D. M.; Pilkington, G. J.


IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating e...

Mihajluk, K.; Simms, C.; Reay, M.; Madureira, Patricia A; Howarth, A.; Murray, P.; Nasser, S.; Duckworth, C. A.; Pritchard, D. M.; Pilkington, G. J.

High grade gliomas (HGGs) are aggressive primary brain tumours with local invasive growth and poor clinical prognosis. Clinical outcome is compounded by resistance to standard and novel therapeutics. We have evaluated reformulated aspirin (IP1867B) alone and in combination with conventional and novel anti-aHGG agents. We show that recent biopsy-derived aHGG models were highly resistant to conventional therapeut...


2 Results

Queried text

Refine Results

Author













Date



Document Type



Access rights


Resource


Subject